A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.
Federico
A
A
Trappoliere
M
M
Tuccillo
C
C
de Sio
I
I
Di Leva
A
A
Del Vecchio Blanco
C
C
Loguercio
C
C
D004338:Drug Combinations; D005234:Fatty Liver / Q000188:drug therapy*; D006801:Humans; D007333:Insulin Resistance; D010743:Phospholipids / Q000627:therapeutic use; D000077385:Silybin; D012838:Silymarin / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D004338:Drug Combinations; D010743:Phospholipids; D012838:Silymarin; D014810:Vitamin E; D000077385:Silybin